跳至主要内容
临床试验/NCT05413460
NCT05413460招募中不适用

Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Complications After Cranial Endovascular Treatment

Zhihong LU1 个研究点 分布在 1 个国家目标入组 158 人开始时间: 2022年7月26日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
158
试验地点
1
主要终点
number of patients with major in-hospital postoperative complications

研究概览

简要总结

In this prospective randomized controlled trial, the subjects will be assigned to group transcutaneous electrical acupoint stimulation (TEAS) and group control (no intervention). The postoperative outcomes including NIHSS (National Institute of Health stroke scale) score, morbidity and mortality will be evaluated during hospital stay and by one year after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

All participants are placed with electrodes at acupoints. The stimulator is put in an opaque box.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥18 years
  • patients scheduled for cranial endovascular treatment

排除标准

  • American Society of Anesthesiologists class Ⅲ or higher
  • Hunt-Hess class Ⅲ or higher
  • body mass index (BMI) < 18 kg/㎡ or > 30kg/㎡
  • large or giant cerebral aneurysms with diameters greater than 15mm and minor cerebral aneurysms with diameters less than 3mm
  • posterior circulation infarction
  • recurrence of an cerebral aneurysms after endovascular procedures or surgical clipping
  • severe abnormal coagulation function, severe liver and kidney function damage, or combined with heart and respiratory system failure
  • injury or infection of the skin around the acupoint area
  • participate in other clinical researchers within 3 months
  • history of neurological or psychiatric diseases
  • patients with implanted electrophysiological device
  • use of sedative or analgesics before surgery
  • patients with difficulty in communication

结局指标

主要结局

number of patients with major in-hospital postoperative complications

时间窗: from end of surgery to discharge from hospital, in an average of 7 days

major complications include myocardial infarction, heart failure, respiratory failure, mechanical ventilation, cerebral infarction, delirium and coma

次要结局

  • serum interleukin-6 level at the end of the surgery(at end of the surgery)
  • mortality by 6 months after surgery(from end of surgery to 6 months after surgery, in a total of 6 months)
  • Score of Mini-mental State Examination at 1 day after surgery(at 24h after the end of surgery)
  • mortality by 30 days after surgery(from end of surgery to 30 days after surgery, in a total of 30 days)
  • mortality by 3 months after surgery(from end of surgery to 3 months after surgery, in a total of 3 months)
  • serum tumor necrosis factor-α level at the end of the surgery(at end of the surgery)
  • episodes of hypotension during surgery(from start of surgery to end of surgery, in an average of 2 hours)
  • Score of Mini-mental State Examination at 3 days after surgery(at 72h after the end of surgery)
  • visual analog scale of pain at 1 day after surgery(at 24h after the end of surgery)
  • number of patients with major postoperative complications by 3 months after surgery(from end of surgery to 3 months after surgery, in a total of 3 months)
  • visual analog scale of pain at 3 days after surgery(at 72h after the end of surgery)
  • Rankin's score at 3 days after surgery(at 72h after the end of surgery)
  • number of patients with major postoperative complications by 6 months after surgery(from end of surgery to 6 months after surgery, in a total of 6 months)
  • duration of postoperative in-hospital stay(from end of surgery to discharge from hospital, in an average of 7 days)
  • Quality of recovery score at 3 days after surgery(at 72h after the end of surgery)

研究者

发起方
Zhihong LU
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Zhihong LU

Professor

Air Force Military Medical University, China

研究点 (1)

Loading locations...

相似试验